Table 1.
mCRC cohort | Non-CRC cohort | Overall | |
---|---|---|---|
Characteristics | n = 32 (%) | n = 7 (%) | n = 39 (%) |
Median age (range) | 61.6 | 64.0 | 61.8 |
(26.6–79.3) | (35.8–69.5) | (26.6–79.3) | |
Gender | |||
Female | 18 (56) | 5 (71) | 23 (59) |
Male | 14 (44) | 2 (29) | 16 (41) |
ECOG | |||
0 | 19 (59) | 3 (43) | 22 (56) |
1 | 13 (41) | 4 (57) | 17 (44) |
Non-CRC subtype | |||
Breast cancer | 0 (0) | 1 (14) | 1 (14) |
Malignant GIST | 0 (0) | 1 (14) | 1 (14) |
Metastatic ovarian LGSC | 0 (0) | 1 (14) | 1 (14) |
Advanced/metastatic NSCLC | 0 (0) | 4 (57) | 4 (57) |
Prior lines of metastatic therapy | |||
1 | 15 (47) | 1 (14) | 16 (41) |
2 | 17 (53) | 2 (29) | 19 (49) |
3 | 0 (0) | 1 (14) | 1 (3) |
Unknown | 0 (0) | 3 (43) | 3 (7) |
Prior EGFR therapy | |||
Yes | 6 (19) | 0 (0) | 6 (15) |
No | 26 (81) | 7 (100) | 33 (85) |
Abbreviation: LGSC, low-grade serous cancer.